Advancing Treatments for Bladder Cancer: Insights from ASCO GU 2024 - Episode 8

Later-Line Therapies for Metastatic Urothelial Carcinoma

, , ,

Evan Y. Yu, MD, provides insights on treatment approaches for patients with metastatic urothelial carcinoma in the second line and beyond.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer (MIBC)
    EP. 2: Ongoing Research on Neoadjuvant Therapies in Muscle-Invasive Bladder Cancer
    EP. 3: Recent Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer
    EP. 4: Expert Insights on Updates in Adjuvant Therapy for Muscle-Invasive Bladder Cancer
    EP. 5: Emerging Data in Metastatic Urothelial Carcinoma
    EP. 6: Clinical Insights on Recent Data in Metastatic Urothelial Carcinoma
    EP. 7: Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma
    Now Viewing
    EP. 8: Later-Line Therapies for Metastatic Urothelial Carcinoma
    EP. 9: Treatment Sequencing Practices in Metastatic Urothelial Carcinoma
    EP. 10: Exciting New Approaches in Metastatic Urothelial Carcinoma
    EP. 11: Key Takeaways on Updates in Bladder Cancer
    x